NAV Financing in Private Equity: What It Is, Why GPs Love It, and Why LPs Should Be Worried

TL;DR: Your PE fund manager just borrowed against the portfolio you already own — and you probably didn't know. I want you to picture something. You invest $5 million into a private equity fund. The GP acquires a portfolio of companies. Those companies are the collateral backing your investment. Then, without a phone call or a consent form, the GP walks into a bank and borrows against that same portfolio. A new lender now sits ahead of you in the repayment queue. The borrowed money goes out as a distribution — and you have to give it back if performance deteriorates. This is NAV financing, and it is reshaping private equity faster than most LPs realize.

What NAV Financing Actually Is

NAV financing , net asset value financing , is a loan made at the fund level, secured by the entire portfolio of companies the fund owns. Think of it as a mortgage taken out against a house you already bought. The fund's portfolio is the collateral. The GP is the borrower. You, the LP, are the homeowner who never got asked.

This is structurally different from deal-level debt, which sits inside individual portfolio companies and is standard in any leveraged buyout. NAV debt sits above all of that , at the fund entity itself , piling a second layer of borrowing on top of companies that are already leveraged. That is why regulators call it "leverage on leverage."

The market is not small. NAV financing stands at $100 to $150 billion outstanding today. Industry projections put it at $600 to $700 billion by 2030. The average deal size jumped 142% in a single year , from €330 million in 2023 to €800 million in 2024. The category is growing faster than almost any other corner of private credit.

The biggest name in the space is 17Capital. In March 2026, the firm closed its Credit Fund 2 at $7.5 billion, the largest NAV loan fundraise ever recorded. 17Capital has now raised $24 billion in total across its strategies. Other major lenders include Goldman Sachs, Ares, Pemberton, Whitehorse Liquidity Partners, Hark Capital, and Blackstone GSO.

Why GPs Love It

To understand the risk, you first have to understand the appeal , and for GPs, the appeal is substantial.

Private equity funds have a fundamental timing problem. They raise capital, deploy it over three to five years, and then hold portfolio companies for another five to seven years before selling. In a normal exit environment, that cycle works. In the environment we have lived through since 2022 , rising rates, compressed multiples, a near-frozen IPO market , exits have stalled. GPs are sitting on mature assets they cannot sell at prices that make anyone look good.

NAV financing solves several problems at once. First, it generates cash without forcing a sale. A GP can borrow against the portfolio, distribute that cash to LPs, and buy time for the exit environment to improve. Second, it funds follow-on investments in existing portfolio companies without requiring a new capital call , something LPs increasingly resist. Third, it keeps the fund alive and the GP managing fees on a larger asset base, which protects their own economics.

The Leverage on Leverage Problem

Here is where the math gets dangerous. Take a typical buyout fund. The GP acquires companies using 50-60% debt at the portfolio company level. That is already four to five turns of EBITDA in many cases. The portfolio companies carry that debt on their own balance sheets.

Now the GP takes a NAV loan at the fund level. That facility is typically sized at 10-25% of portfolio NAV, but in larger transactions, it can go higher. You now have debt at two separate levels , inside each company, and sitting above the entire portfolio. If the portfolio runs into stress, the fund-level debt accelerates the losses in a way that straight equity exposure does not.

The Bank of England has explicitly flagged this dynamic, warning that "leverage on leverage" with illiquid collateral creates financial stability risks that extend beyond individual funds. When you combine portfolio company debt with fund-level NAV debt, and the collateral is private companies that cannot be sold quickly at fair value, the downside math gets ugly fast.

The SPV Hiding Trick

This is the part that should make every LP reach for their LPA.

Most limited partnership agreements written between 2015 and 2020 include some form of leverage restriction. The LPA might say the fund cannot borrow more than a certain percentage of committed capital or NAV. Those provisions were written to protect LPs from exactly this kind of risk.

GPs have found a workaround. Instead of borrowing directly at the fund level , which would trigger the LPA's leverage calculation , many GPs route NAV facilities through special purpose vehicles that sit outside the fund's legal structure. The debt is real. The collateral is real. The obligation is real. But because it lives in an SPV, it falls outside the leverage limits the LPA was designed to enforce.

Harvard Law's Corporate Governance Forum has documented this structural maneuver in detail. The LP sees distributions arrive. They do not see the debt that funded them. They do not see the SPV. They do not see the repayment obligation sitting above their interest in the capital stack. This is not fraud in most cases , it is technically permitted under older LPA language , but it is a serious governance failure.

Who Gets Paid First

Let me be direct about the capital stack. When a PE fund with a NAV facility goes into distress, here is the repayment order: NAV lenders collect first. They hold a secured interest in the portfolio. LPs collect whatever remains.

This inverts the relationship that LPs thought they had. A NAV loan puts a third party , a private credit fund or a bank , ahead of you in line, secured by assets you funded.

The NAV lender charges a spread for this. In 2024, NAV loan pricing typically ran SOFR plus 300-600 basis points depending on portfolio quality and deal structure. That interest cost comes out of the fund's returns before LPs see a dollar. In a scenario where the fund performs modestly , not badly, just modestly , the NAV facility can consume a meaningful portion of total return.

The Distribution Clawback Risk

ILPA published formal guidance in 2024 warning about this exact risk. When a GP uses a NAV facility to fund a distribution to LPs, that distribution may be subject to recall. If the fund's performance deteriorates after the distribution goes out, LPs may be required to return the cash to satisfy the NAV lender's claim.

Think about what this means in practice. An LP receives a distribution, treats it as a return of capital, redeploys it, and then gets a capital call asking for it back. The LP who spent that distribution now faces a potential liquidity crisis of their own. Most LPA clawback provisions in older agreements do not clearly specify whether NAV-funded distributions carry this recall risk. The ambiguity itself is a problem.

Regulators Are Watching

The regulatory environment around NAV financing is tightening. The SEC named NAV lending as a top examination priority for 2025. Exam teams are looking specifically at disclosure practices , whether GPs are telling LPs about NAV facilities in the first place, and whether the fee and cost implications are being communicated clearly.

LP pushback is already influencing GP behavior at larger institutions. Several major pension funds and sovereign wealth funds have begun including explicit NAV facility consent requirements in their side letter negotiations. When the biggest LPs in the world start putting this in writing, it tells you something about the risk they perceive.

What LPs Should Demand in New LPAs

If you are negotiating a new fund commitment today, here is the minimum you should ask for. First, explicit prior consent for any NAV facility above a defined threshold. Second, inclusion of NAV facility debt in the fund's leverage calculation, with no SPV carveout. Third, quarterly disclosure of all outstanding fund-level borrowings, the lender, the interest rate, and the maturity date. Fourth, clear language specifying whether distributions funded by NAV facilities are subject to recall.

LPAs written after 2022 increasingly include some of these provisions. LPAs from 2015 to 2020 typically do not. If you are in an older fund, you are likely operating under a document that gives the GP broad discretion you did not fully anticipate when you signed.

Questions to Ask Your GP Today

I would ask every GP in my portfolio the following questions. Does the fund currently have any outstanding NAV financing or fund-level credit facilities beyond a standard subscription line? If yes, what is the outstanding balance, the lender, the interest rate, and the maturity? Was the facility disclosed to the LP Advisory Committee? How does the fund's LPA treat fund-level borrowings in its leverage calculation? And finally, if distributions were funded in part by a NAV facility, what are the recall provisions?

A GP with nothing to hide answers these questions in one email. Evasive or delayed responses tell you something.

NAV financing is not inherently predatory. Used carefully, with full disclosure and genuine LP consent, it can bridge a liquidity gap in a fund that holds genuinely good assets in a temporarily bad exit environment. The problem is the opacity. The $600-700 billion market projected for 2030 will include funds that use it responsibly, and funds that use it to paper over losses and protect GP economics at LP expense. Right now, you often cannot tell the difference from the outside. That is the problem worth solving.

Author Disclosure: Jeff Barnes, MBA has no personal position in any company, fund, or platform named in this article. Angel Investors Network has no current commercial relationship with any party mentioned. AIN provides marketing and education services, not investment advice. Past performance does not guarantee future results. All investments involve risk, including loss of principal.